Equity Overview
Price & Market Data
Price: $0.56
Daily Change: +$0.0195 / 3.48%
Range: $0.512 - $0.563
Market Cap: $5,371,762
Volume: 753,072
Performance Metrics
1 Week: -9.29%
1 Month: -33.82%
3 Months: -87.56%
6 Months: -95.03%
1 Year: -99.82%
YTD: -91.80%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was founded in 2019 and is based in Naples, Florida.